GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Staar Surgical Co (NAS:STAA) » Definitions » Change in Organic Revenue %

Staar Surgical Co (Staar Surgical Co) Change in Organic Revenue % : 5.00% (As of Mar. 2024)


View and export this data going back to 1983. Start your Free Trial

What is Staar Surgical Co Change in Organic Revenue %?

Organic revenue is revenue generated from within a company that is a direct result of the firm's existing operations. Change in Organic Revenue % provides management and investors with the level of revenue change that was generated from the sale of a company's products and services.

Staar Surgical Co's Change in Organic Revenue % for the quarter that ended in Mar. 2024 was 5.00% , which is lower than 19.00% for the pervious quarter ended in Dec. 2023.

Staar Surgical Co's Change in Organic Revenue % for the annual that ended in Dec. 2023 was 18.00% , which is lower than 29.00% for the pervious year ended in Dec. 2022.

The historical rank and industry rank for Staar Surgical Co's Change in Organic Revenue % or its related term are showing as below:

STAA's Change in Organic Revenue % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median:
* Ranked among companies with meaningful Change in Organic Revenue % only.

Staar Surgical Co Change in Organic Revenue % Historical Data

The historical data trend for Staar Surgical Co's Change in Organic Revenue % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Staar Surgical Co Change in Organic Revenue % Chart

Staar Surgical Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Change in Organic Revenue %
Get a 7-Day Free Trial Premium Member Only Premium Member Only

Staar Surgical CoQuarterly Data
Trend Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Change in Organic Revenue %
Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only

Competitive Comparison of Staar Surgical Co's Change in Organic Revenue %

For the Medical Instruments & Supplies subindustry, Staar Surgical Co's Change in Organic Revenue %, along with its competitors' market caps and Change in Organic Revenue % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Staar Surgical Co  (NAS:STAA) Change in Organic Revenue % Explanation

Organic revenue is the product of the internal processes of a company and are generated solely within the firm minus cost of goods sold (COGS). It’s similar to the gross income. Organic revenue provides management and investors with the level of revenue that was generated from the sale of a company's products and services.

If the change in organic revenue is positive, then the company generates increases in organic revenue, which is typically referred to as organic growth. Once an acquisition is fully integrated into a company's existing operations, sales from the acquired unit or business would then be counted as organic sales.

Organic revenue is important because it doesn't include taxes and other one-off items that may skew a company's profit in a given year. The changing of the organic revenue also reflects the company’s core business profitability is increasing, especially when an acquisition happened. It is a more reliable index than gross income at that time because the performance of newly acquired businesses may change in the future.


Staar Surgical Co (Staar Surgical Co) Business Description

Traded in Other Exchanges
Address
25651 Atlantic Ocean Drive, Lake Forest, CA, USA, 92630
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also make lenses which are used in surgery that treats cataracts. The company offers products are ICLs used in refractive surgery and IOLs used in cataract surgery. The company generated sales are from the ophthalmic surgical product segment.
Executives
Broadwood Partners Lp 10 percent owner BROADWOOD CAPITAL INC., 142 WEST 57TH STREET, 11TH FLOOR, NEW YORK NY 10019
Elizabeth Yeu Lin director 25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA 92630
Aimee S Weisner director ONE EDWARDS WAY, IRVINE CA 92614
Warren Foust officer: Chief Operating Officer 17 MAGNOLIA DRIVE, LADERA RANCH CA 92694
Magda Michna officer: Chief Clinical, Regulatory, C/O PRESBIA, 8845 IRVINE CENTER DRIVE, SUITE 100, IRVINE CA 92618
Keith Holliday officer: V.P., Research & Development 1911 WALKER AVENUE, MONROVIA CA 91016
Robert Studholme officer: Senior VP, Operations 25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA 92630
James E Francese officer: VP, Global Marketing 1911 WALKER AVE, MONROVIA CA 91016
Caren L Mason director 2523 PARK RIDGE DRIVE, ESCONDIDO CA 92025
Samuel J Gesten officer: VP, General Counsel 1911 WALKER AVENUE, MONROVIA CA 91016
Patrick F. Williams officer: Chief Financial Officer C/O ZELTIQ AESTHETICS INC., 4698 WILLOW ROAD, SUITE 100, PLEASANTON CA 94588
Hans-martin Blickensdoerfer officer: VP, International Marketing 1911 WALKER AVENUE, MONROVIA CA 91016
Lou Silverman director
Graydon C. Hansen officer: Sr. VP, Global Operations 25651 ATLANTIC OCEAN DRIVE, LAKE FORST CA 92630
Jon K. Hayashida officer: VP, Global Clinical, Medical 25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA 92630